Company intelligence / Profile preview

Decideum

London, United Kingdom

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Decideum is a specialized market access and health economics consultancy that supports pharmaceutical and biotechnology companies in securing product reimbursement and patient access. Based in London, the firm is renowned for its expertise in navigating the UK's National Institute for Health and Care Excellence (NICE) and other Health Technology Assessment (HTA) bodies. Their core services include value proposition development, evidence synthesis, and strategic policy engagement. In November 2020, Decideum was acquired by Fishawack Health (now Avalere Health), integrating its capabilities into a broader global healthcare commercialization platform. The company continues to operate as a key component of Avalere Health's market access and HEOR division.

Industry: Consulting

Beyond the preview

Go deeper on Decideum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decideum.

Explore the full profile